Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Confirmation of association of IL-15 with pediatric asthma and comparison of different controls.

Authors: Bierbaum, S  Nickel, R  Zitnik, S  Ahlert, I  Lau, S  Deichmann, KA  Wahn, U  Heinzmann, A 
Citation: Bierbaum S, etal., Allergy. 2006 May;61(5):576-80.
Pubmed: (View Article at PubMed) PMID:16629787
DOI: Full-text: DOI:10.1111/j.1398-9995.2006.01059.x

BACKGROUND: Interleukin (IL)-15 is an important mediator in chronic inflammatory diseases. Recently, we have described the association of IL-15 haplotypes with bronchial asthma. Asthma genetics is highly complex - about every second candidate gene is not confirmed in consecutive studies. We were interested in whether association of asthma with IL-15 holds in a second population. Furthermore, we sought to investigate the effect of different controls. METHODS: Five IL-15 polymorphisms were genotyped on the German Multicenter Allergy Study (MAS) cohort consisting of 886 children who were followed up from birth to 10 years of age. At 10 years of age, 96 were found to be asthmatic. MAS children who never had any wheezing symptoms (n = 576), who were never diagnosed with asthma (n = 790) and 129 super controls who had never had any atopic disorder were used as controls. Finally, 270 randomly chosen adults served as controls. RESULTS: Association was confirmed with single polymorphism and haplotypes. The super controls showed the highest difference to the asthmatics regarding haplotype frequencies. However, the effect escaped statistical significance, most likely because of the small sample size. CONCLUSION: Association of IL-15 with asthma was confirmed. Although super controls might be the most suitable, more numbers are needed. This might hamper the value of these controls especially when investigating common diseases.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 4984421
Created: 2011-03-01
Species: All species
Last Modified: 2011-03-01
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.